









市场行情
/
股票
/
nasdaq-sdgr
/

Schrodinger Inc

SDGR

18.310USD

-0.070-0.38%

收盘 12/26, 16:00（美东）报价延迟15分钟

1.35B总市值

亏损市盈率 TTM



Schrodinger Inc

18.310

-0.070-0.38%

概览公司财务分析

概览

公司

财务

分析

关于 Schrodinger Inc 公司

Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.

Schrodinger Inc简介



公司代码SDGR

公司名称Schrodinger Inc

上市日期Feb 06, 2020

CEOFarid (Ramy Farid)

员工数量891

证券类型Ordinary Share

年结日Feb 06

公司地址1540 Broadway

城市NEW YORK

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编10036

电话15032991150

网址https://www.schrodinger.com

公司代码SDGR

上市日期Feb 06, 2020

CEOFarid (Ramy Farid)

Schrodinger Inc公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Richard A. Friesner, Ph.D.

Director

1.24M

+0.49%

Mr. Kenneth Patrick (Patrick) Lorton

Executive Vice President, Chief Operating Officer - Software

36.99K

-30.96%

Ms. Margaret Dugan, M.D.

Chief Medical Officer

24.57K

-5.37%

Ms. Yvonne Tran, J.D.

Chief People Officer, Executive Vice President, Chief Legal Officer

23.64K

+112.26%

Mr. Arun Oberoi

Independent Director

12.25K

+95.95%

Dr. Rosana Kapeller-Libermann, M.D., Ph.D.

Independent Director

12.25K

+95.95%

Ms. Bridget Anne Van Kralingen

Independent Director

11.50K

+14.99%

Mr. Michael Lynton

Independent Chairman of the Board

Mr. Mannix Aklian

Executive Vice President, Chief Commercial Officer, Global Head of Software Sales & Marketing

Mr. Gary Ginsberg, J.D.

Independent Director

名称

名称/职务

职务

持股

持股变动

Dr. Richard A. Friesner, Ph.D.

Director

1.24M

+0.49%

Mr. Kenneth Patrick (Patrick) Lorton

Executive Vice President, Chief Operating Officer - Software

36.99K

-30.96%

Ms. Margaret Dugan, M.D.

Chief Medical Officer

24.57K

-5.37%

Ms. Yvonne Tran, J.D.

Chief People Officer, Executive Vice President, Chief Legal Officer

23.64K

+112.26%

Mr. Arun Oberoi

Independent Director

12.25K

+95.95%

Dr. Rosana Kapeller-Libermann, M.D., Ph.D.

Independent Director

12.25K

+95.95%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

On-premise software

15.74M

28.75%

Drug discovery services

13.94M

25.46%

Hosted software

11.13M

20.32%

Software maintenance

6.78M

12.38%

Contribution

4.51M

8.24%

其他

2.66M

4.85%

地区USD

名称

营收

占比

United States

34.05M

62.18%

EMEA

13.56M

24.77%

APAC

6.97M

12.73%

Rest of World

175.00K

0.32%

业务

地区

业务USD

名称

营收

占比

On-premise software

15.74M

28.75%

Drug discovery services

13.94M

25.46%

Hosted software

11.13M

20.32%

Software maintenance

6.78M

12.38%

Contribution

4.51M

8.24%

其他

2.66M

4.85%

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

12.55%

Bill & Melinda Gates Foundation Trust

10.82%

The Vanguard Group, Inc.

9.81%

Rubric Capital Management LP

8.17%

Amova Asset Management Co., Ltd.

7.06%

其他

51.59%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

12.55%

Bill & Melinda Gates Foundation Trust

10.82%

The Vanguard Group, Inc.

9.81%

Rubric Capital Management LP

8.17%

Amova Asset Management Co., Ltd.

7.06%

其他

51.59%

股东类型

持股股东

占比

Investment Advisor

47.56%

Investment Advisor/Hedge Fund

29.79%

Hedge Fund

15.33%

Endowment Fund

10.82%

Research Firm

3.00%

Individual Investor

2.64%

Bank and Trust

1.57%

Pension Fund

0.90%

Venture Capital

0.17%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

545

71.77M

111.28%

-2.08M

2025Q2

572

66.46M

103.14%

-5.60M

2025Q1

593

67.21M

104.69%

-5.43M

2024Q4

576

64.44M

100.89%

-9.04M

2024Q3

581

67.44M

105.91%

-6.15M

2024Q2

573

64.76M

101.80%

-8.12M

2024Q1

574

63.48M

100.05%

-5.40M

2023Q4

584

62.06M

98.56%

-7.64M

2023Q3

586

63.62M

101.35%

-15.42M

2023Q2

584

64.04M

102.20%

-7.30M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

8.17M

12.68%

+419.13K

+5.41%

Jun 30, 2025

Bill & Melinda Gates Foundation Trust

6.98M

10.83%

Jun 30, 2025

The Vanguard Group, Inc.

6.60M

10.25%

+74.93K

+1.15%

Jun 30, 2025

Rubric Capital Management LP

5.00M

7.76%

+200.00K

+4.17%

Jun 30, 2025

Amova Asset Management Co., Ltd.

3.65M

5.66%

+187.53K

+5.42%

Jun 30, 2025

Lazard Asset Management, L.L.C.

1.42M

2.2%

-198.96K

-12.30%

Jun 30, 2025

State Street Investment Management (US)

2.19M

3.39%

-26.19K

-1.18%

Jun 30, 2025

Stephens Investment Management Group, LLC

2.26M

3.51%

+291.39K

+14.79%

Jun 30, 2025

MFS Investment Management

1.49M

2.32%

-598.55K

-28.60%

Jun 30, 2025

ARK Investment Management LLC

1.96M

3.04%

-335.26K

-14.61%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

ARK Genomic Revolution ETF

3.63%

Clough Select Equity ETF

3.12%

TrueShares Technology, AI & Deep Learning ETF

1.99%

Global X HealthTech ETF

1.14%

State Street SPDR FactSet Innovative Technolgy ETF

0.84%

Franklin Exponential Data ETF

0.82%

WisdomTree BioRevolution Fund

0.77%

Invesco S&P SmallCap Health Care ETF

0.72%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.47%

First Trust Multi-Manager Small Cap Opportunities ETF

0.47%

ARK Genomic Revolution ETF

占比3.63%

Clough Select Equity ETF

占比3.12%

TrueShares Technology, AI & Deep Learning ETF

占比1.99%

Global X HealthTech ETF

占比1.14%

State Street SPDR FactSet Innovative Technolgy ETF

占比0.84%

Franklin Exponential Data ETF

占比0.82%

WisdomTree BioRevolution Fund

占比0.77%

Invesco S&P SmallCap Health Care ETF

占比0.72%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比0.47%

First Trust Multi-Manager Small Cap Opportunities ETF

占比0.47%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Schrodinger Inc的前五大股东是谁？



Schrodinger Inc 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：8.17M，占总股份比例：12.68%。
Bill & Melinda Gates Foundation Trust持有股份：6.98M，占总股份比例：10.83%。
The Vanguard Group, Inc.持有股份：6.60M，占总股份比例：10.25%。
Rubric Capital Management LP持有股份：5.00M，占总股份比例：7.76%。
Amova Asset Management Co., Ltd.持有股份：3.65M，占总股份比例：5.66%。